Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China flag China · Delayed Price · Currency is CNY
18.71
-0.17 (-0.90%)
Feb 3, 2026, 11:34 AM CST

SHE:000623 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
1,2151,1071,7201,4381,7432,504
Short-Term Investments
---788704709
Trading Asset Securities
1,8941,5681,6581,6402,1891,300
Cash & Short-Term Investments
3,1092,6753,3783,8664,6354,513
Cash Growth
4.81%-20.81%-12.62%-16.59%2.71%-1.66%
Accounts Receivable
992.951,1571,4071,056964.31951.03
Other Receivables
182.5923.1829.9860.3168.5383.35
Receivables
1,1761,1811,4371,1161,0331,034
Inventory
879.19936.9872.35874.57591.88548.45
Prepaid Expenses
----0.160.01
Other Current Assets
55.5240.4157.55124.6965.5987.41
Total Current Assets
5,2204,8335,7455,9826,3266,183
Property, Plant & Equipment
2,4752,5582,5342,3392,2962,246
Long-Term Investments
26,00724,64723,00321,89119,63718,283
Other Intangible Assets
453.96437.32435.35365.08359.61329.44
Long-Term Deferred Tax Assets
251.28326.23309.84303.12164.27118.52
Long-Term Deferred Charges
82.86111.57163.96212.25188.02126.37
Other Long-Term Assets
86.1188.3375.7789.8396.5367.6
Total Assets
34,57633,00232,26631,18229,06727,353
Accounts Payable
360.65425.71418.59450.97238.22262.56
Accrued Expenses
46.29106.87148.94183.15111.71107.5
Short-Term Debt
1,1421,255678.31651.27355.52373.38
Current Portion of Long-Term Debt
--2,315---
Current Portion of Leases
12.6322.4817.8818.2325.41-
Current Income Taxes Payable
26.175.928.2811.5219.319.21
Current Unearned Revenue
29.0934.6926.2682.2518.3619.95
Other Current Liabilities
820.19613.31834.8817.97687.19611.45
Total Current Liabilities
2,4372,4644,4682,2151,4561,384
Long-Term Debt
1,087995.22-2,3032,2112,108
Long-Term Leases
5.516.5121.4917.5523.38-
Long-Term Unearned Revenue
215.26223.87247.38281.6313.86321.31
Long-Term Deferred Tax Liabilities
14.120.1730.0326.0624.219.9
Other Long-Term Liabilities
-----0.5
Total Liabilities
3,7593,7204,7674,8444,0293,824
Common Stock
1,1961,1961,1681,1631,1631,163
Additional Paid-In Capital
4,8974,8524,0353,9473,9803,965
Retained Earnings
24,14022,46621,87120,74119,24317,690
Treasury Stock
-420.01-300-720.07-570.07-400.03-300.03
Comprehensive Income & Other
754.5814.1856.99753.71873.11834.39
Total Common Equity
30,56829,02827,21226,03424,85923,353
Minority Interest
249.03254.65288.01303.54179.26176.26
Shareholders' Equity
30,81729,28227,50026,33825,03923,529
Total Liabilities & Equity
34,57633,00232,26631,18229,06727,353
Total Debt
2,2472,2893,0322,9902,6162,482
Net Cash (Debt)
862.39385.96346.02875.842,0202,031
Net Cash Growth
9.36%11.54%-60.49%-56.63%-0.57%-18.61%
Net Cash Per Share
0.730.330.270.671.601.59
Filing Date Shares Outstanding
1,1721,1721,1231,1271,1391,139
Total Common Shares Outstanding
1,1721,1801,1231,1271,1391,145
Working Capital
2,7822,3691,2773,7674,8704,799
Book Value Per Share
26.0724.6124.2323.1021.8320.39
Tangible Book Value
30,11428,59026,77625,66924,50023,024
Tangible Book Value Per Share
25.6924.2423.8422.7821.5120.11
Buildings
-2,2872,2022,1382,0391,991
Machinery
-1,5121,4911,4131,3211,265
Construction In Progress
-424.87349.54177.36179.32133
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.